E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers H > Headlines for Horizon Therapeutics plc > News item
Published on 5/16/2019 in the Prospect News CLO Daily and Prospect News High Yield Daily.

Horizon update surfaces; McGraw-Hill/Cengage tables loan; Cetera, Nautilus disclose talk

By Sara Rosenberg

New York, May 16 – In the primary market on Thursday, Horizon Therapeutics plc (Horizon Pharma USA Inc.) modified the original issue discount on its term loan B, and McGraw-Hill/Cengage shelved its amended and extended first-lien term loan.

Furthermore, Cetera Financial Group and Nautilus Power LLC released price talk on their proposed term loans with launch.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.